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1. Introduction 
Hypospadias is a common congenital anomaly, the cause of which is still unknown. The 
term hypospadias is derived from the Greek prefix “hypo” meaning bellow and the term 
“spadon”, meaning rent or defect (Dorland’s Medical History, 1981).    
The defect is readily observed, and hence it has been recognised since ancient times 
(Aristotle. Generation of animals, 1943). In both males and females the urethra is a perfect 
canal, but in the congenital anomaly of hypospadias, the canal becomes a gutter. This 
phenomenon is easily seen in males but not in females. In females anomalies of the urethral 
meatus are considered anomalies of the urogenital sinus (J.E. Skandalakis & S.W.Gray, 
1994).  The term “hypospadias” refers to an opening on the ventral side of the penis, while 
“epispadias” is an opening on the dorsal side. Hypospadias denotes a condition in which 
the urethra has failed to completely form and is often associated with a ventral curvature of 
the penis (chordee). Hypospadias is classified according to severity. The first degree is the 
mildest form, and the urethra opens on the anterior portion of the penis (glandular and 
subcoronal). The second degree is more severe and involves openings on the midshaft of the 
penis. The third degree is the most severe and involves posterior penile, penoscrotal, scrotal, 
and perineal openings. First-degree hypospadias accounts for approximately 50% of cases, 
second-degree for 30%, and third-degree for 20% (Duckett et al, 1996; Levitt SB & Reda, 1988).  
2. Embryology of hypospadias 
The development and elongation of the phallus occurs between weeks 8 and 14 of prenatal 
life under the influence of the androgens testosterone (T) and 5┙ dihydrotestosterone (DHT), 
which are synthesized in response to a surge of luteinizing hormone (LH) from the fetal 
pituitary (Moore KL, 1988; Bingol N & Wasserman, 1990).  
Testosterone is a key hormonal agent that influences the undifferentiated fetal sex organs, 
including internal and external genitalia, to develop into the male phenotype. The placenta 
regulates the production of fetal testosterone by the stimulatory effect of human chorionic 
gonadotropin-(hCG)- on Leydig cells at an early stage of gestational age, including the 
critical 8th–12th weeks for male genitalia development (Winter et al.,1977).  
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The fetal pituitary begins to regulate the production of testosterone at midgestation by the 
secretion of luteinizing hormone (LH). The growth and development of the testis and 
accessory sex structures in the human, are unequivocally dependent upon the continuous 
support of the hypothalamo-hypophyseal-testicular axis (Grumbach, M.M., 1980; Claude 
Desjardins 1981).  
At the end of the third month, the urethral folds close over the urethral plate to form the 
penile urethra. The distal part of the glanular urethra, develops by one of the following 
mechanisms (Gunha GR & Baskin LS., 2004). The classic theory states that the distal portion 
of the urethra develops as an in growth from the tip of the penis until it joins the proximal 
tubular urethra (Moore KL et al., 2003; Kurzrock EA et al. 1999) Recent evidence, however, 
suggests that the entire urethra from base to tip, is formed by continuous extension and 
fusion of the endodermal urethral groove (Hynes PJ & Fraher JP, 2004; Belman AB., 2002).   
The penile urethra forms as a result of the medial edges of the endodermal urethral folds 
fusing to form the median raphe (Baskin LS., 2000). 
Undescended testes (cryptorchidism) and inguinal hernias are urogenital anomalies that are 
most commonly associated with hypospadias. In one series, 9.3% of hypospadias patients 
had undescended testes (Khuri FJ et al., 1981). There was a 5% incidence of undescended 
testes with first-degree, 6% with second-degree, and 32% with third-degree hypospadias. 
The overall occurrence of inguinal hernia associated with hypospadias is estimated to be 9%, 
but with third degree hypospadias the occurrence can be as high as 17% (Khuri FJ et al., 
1981).  Congenital anomalies not involving the urogenital tract have been found in 6.7% of 
all patients with hypospadias, and primarily involve the craniofacial, cardiothoracic, and 
gastrointestinal systems and the extremities. With increasing severity of hypospadias, the 
occurrence of associated non-urogenital anomalies can reach 12.7% (Latifoglu et al., 1998).  
3. Epidemiology 
Recent evidence shows an increase in the prevalence of hypospadias in Europe and US 
without certain aetiology (Paulozzi LJ et al., 1997; Paulozzi LJ, 1999). Classical textbooks of 
embryology and Paediatric Surgery report that the incidence of hypospadias is ranging from 
1-8.2 per 1000 live male births (J.E. Skandalakis & S.W.Gray, 1994; Ashcraft Murphy, 2000; 
O’Neil, J, et al, 2006).  Hypospadias is a relatively common congenital anomaly, with a birth 
prevalence ranging from 0.3% to 0.8% of Caucasian male live births in the United States, and 
0.05% to 0.4% for other racial groups (Bingol N & Wasserman, 1990). A greater frequency of 
hypospadias has been found in Caucasians than in other races (Chavez GF et al., 1988; 
Gallentine ML et al., 2001). In the 1970s and 1980s, birth defect surveillance systems reported 
transient 1.5- to 2-fold increases in the prevalence of hypospadias in Norway, (Bjerkedal T & 
Bakketeig LS., 1975) Sweden, (Kallen B & Winberg J., 1982) Denmark, (Kallen B et al., 1986) 
England, (Matlai P & Beral V, 1985) and Hungary (Czeizel A., 1985).  
An international study of hypospadias from seven birth defect surveillance programs 
(Denmark, Hungary, Italy, Mexico, South America, Spain and Sweden) included data from 
over 7,400 cases of nonsyndromic hypospadias (Kallen B et al., 1986). Differences in 
prevalence rates between countries were found that could not be explained completely by 
variations in case definition or different levels of ascertainment. The inclusion of less severe 
forms of hypospadias did not explain the higher rates in some programs compared to 
others. In some countries there was a 5–21% level of over estimation due to misdiagnosis of 
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normal infants. Counteracting this was a 30–64% under estimation among cases severe 
enough to require surgery. However, geographic variability in prevalence rates could not be 
explained solely on the basis of ascertainment problems. 
Rates based on Swedish registry data from 1973–1974 (incomplete ascertainment) were 40% 
higher than rates from 1965–1968 based on hospital records and registry data (more 
complete ascertainment) (Kallen B & Winberg J., 1982). Consequently, hypospadias is 
difficult to assess in studies utilizing data from geographically diverse surveillance 
programs (Kallen B et al., 1986).  
A Centers for Disease Control (CDC) study evaluated the birth prevalence of hypospadias in 
the United States from two birth defects surveillance systems: the Metropolitan Atlanta 
Congenital Defects Program (MACDP) and the Birth Defects Monitoring Program (BDMP) 
(Paulozzi LJ et al., 1999). The MACDP is a hospital-based registry that was initiated in 1968 
and is based on case ascertainment in 22 hospitals and clinics in the Atlanta, Georgia area. 
The BDMP is a population-based registry that was initiated in 1970, in which diagnoses 
from newborn discharge summaries are collected from a nationwide sample of hospitals 
(Paulozzi LJ et al., 1999). The total hypospadias rate (mild and severe) doubled in the 
MACDP between 1968 and 1993 from approximately 1.5 to 3.0/1000 births, and the overall 
trend was statistically significant. The annual rate of increase was 2.9%, and the overall 
increase occurred at a rate of 1.4% per year among Caucasians and 5.7% per year among 
non-Caucasians. For severe hypospadias, the rate increased three- to five-fold (0.11–
0.55/1000 births) from 1968 to 1993, and this trend was also statistically significant. Overall, 
however, approximately 60% of cases could not be classified by severity. In the BDMP, the 
total hypospadias rate also doubled (2.02 to 3.97/1000 births) from 1970 to 1993, and this 
trend was also statistically significant. The increase occurred nationwide, and was highest in 
the Southeast and lowest in the West (Paulozzi LJ et al., 1999).  
The prevalence of hypospadias was assessed in The Netherlands by prospective 
examination of newborns in Rotterdam over a 2-year period. A total of 7292 consecutive 
male births were examined for the presence of hypospadias (excluding glandular cases), and 
rates were increased four-fold compared to earlier time periods studied (Pierik FH et 
al.,2002).  
Consequently, comparable rates of increases in the birth prevalence of hypospadias have 
been seen in both the United States as well as in The Netherlands in studies utilizing 
population-based as well as hospital-based epidemiologic approaches (Paulozzi LJ et al., 
1999). A recent study from Denmark reports a rate of hypospadias of about 1% in a 
population of 1072 boys studied at birth which increased to almost 5% when followed for 3 
years (K.A.Boisen, et al, 2005).  
On the other hand studies reporting prevalence rates of hypospadias in Washington State 
and California do not support the idea of increased prevalence during the periods of 1987-
2002 and 1989-1997 respectively (Susan L. Carmichael et al., 2003; Michael P. Porter et al, 
2005).  
Reviewing the international literature on the epidemiology of hypospadias one cannot stress 
enough the difficulties that arise when comparing different studies with variations in 
inclusion criteria and even definition of the different forms of the disease. The differences in 
ascertainment and in the descriptive epidemiology of hypospadias pose a question as to 
whether the reported increase in prevalence by some authors is true. However increasing 
trends are being reported by recent careful studies concerning some populations (Michael 
Michalakis, et al. 2008; A.M.Tsatsakis et al., 2008). 
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4. Etiology 
Reports of increasing prevalence of hypospadias have raised questions concerning 
aetiology, treatment, and prevention. To date, there is no comprehensive understanding of 
the aetiology of hypospadias that can inform primary prevention efforts and improve 
therapeutics. The aetiology of many hypospadias is often assumed to be multifactorial, 
implicating some combination of genes and environment in the development of the 
anomaly. Efforts to define a clear aetiology have been unsuccessful (Baskin LS et al., 2001). 
In a report, 33 patients with severe (scrotal or penoscrotal) hypospadias were evaluated with 
a range of diagnostic techniques including clinical assessment, ultrasonography, 
karyotyping, endocrine evaluation, and molecular genetic analysis of the androgen receptor 
(AR) and 5┙-reductase genes to classify and determine the cause of the hypospadias (Albers 
N, 1997). In 12 patients, diagnoses were determined. The remaining 64% of patients were 
classified as hypospadias of unknown aetiology. 
5. Genetic predisposition forhypospadias 
There is a well recognized familial clustering of hypospadias, and male relatives of boys 
with hypospadias are more likely to have this condition than would be expected by chance. 
In a study by Sorenson, (Sorenson HR., 1953) male relatives of 103 index cases with 
nonsyndromic hypospadias were evaluated. It was found that 28% had at least one other 
family member with hypospadias. The more severe the hypospadias in the index case, the 
higher the incidence of hypospadias in first-degree relatives. With the mildest form of 
hypospadias, 3.5% of relatives were affected; with second-degree, 9.1%; and with third-
degree, 16.7%. The overall risk for a brother of an affected infant to also have hypospadias 
was 9.6%. Chen and Woolley (Chen YC, 1971) identified a similar figure of 9.7%. The risk of 
hypospadias in sibs of affected infants was found to be 4.2% in the international study, with 
a range of 0–11.3% (Kallen B et al, 1986). These sib occurrence risks are compatible with a 
multifactorial mode of inheritance for hypospadias. An increased risk for hypospadias 
among twins has been described. The prevalence of hypospadias is higher among members 
of male–male pairs and lower among males in male–female pairs. Concordance among 
twins of the same sex was 18% for both mild and severe forms, with increased risk evident 
in both monozygotic and dizygotic twins (Kallen B et al, 1986). When monozygotic twins 
discordant for hypospadias were evaluated, the twin with the lowest birth weight had 
hypospadias in 16 out of 18 pairs, suggesting a gene-environment interaction (Fredell L et 
al., 1988). 
6. Genetic impairment 
Theoretically, genetic alterations in any of the genes involved in development of the male 
urogenital system could result in hypospadias. However, currently only a small percentage 
of hypospadias has been linked to genetic or chromosomal damage (Bentvelsen FM et al., 
1995; Aaronson IA et al., 1997; Alléra A. et al., 1995).  
One in nine patients with severe hypospadias had a single amino acid replacement of the 
Androgen receptor gene (AR) (Alléra A. et al., 1995). Single-strand conformational 
polymorphism analysis revealed a missense mutation of exon 2 of the AR gene in 1 of 40 
patients with distal hypospadias (Sutherland RW et al., 1996). Several other authors 
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concluded that mutations in the AR gene are rarely associated with hypospadias, (Wilson JD 
et al., 1981; McPhaul MJ et al., 1993; McPhaul MJ et al., 1993;– Hiort O et al., 1994) implying 
that other factors are responsible. 
6.1 Homeobox (HOX) genes 
Homeobox (HOX) genes are transcription factors that play a role in embryonic organization 
and patterning. Genes of the Hoxa and Hoxd clusters are expressed in regionalized domains 
along the axis of the urogenital tract. 
Transgenic mice with loss of function of single Hoxa or Hoxd genes exhibit homeotic 
transformations and impaired morphogenesis of the urogenital tract (Dollé P et al., 1991; 
Benson GV et al., 1996; Hsieh-Li HM et al., 1995; Podlasek CA et al., 1997). Human males 
with hand–foot–genital syndrome, an autosomal dominant disorder characterized by 
mutations in HOXA13, exhibit hypospadias of variable severity, suggesting that HOXA13 
may be important in normal patterning of the penis (Mortlock DP & Innis JW, 1997; 
Donnenfeld AE et al., 1991; Fryns JP et al., 1993). 
6.2 Fibroblast growth factor (FGF) genes 
Fibroblast growth factor (FGF) genes have been demonstrated to play a role in genital 
tubercle development. As with Hoxa-13, Fgf-10 and insulin-like growth factor receptor (Igfr) 
knockout mice have been shown to develop hypospadias. More specifically, the condition of 
the external genitalia Fgf-10 knockout mice suggests impairment in the development of the 
glans penis (Haraguchi R et al., 2000). 
6.3 The Sonic hedgehog (Shh) gene 
Genetic mutations might also interfere with epithelial–mesenchymal interactions necessary 
for normal embryogenesis (Kurzrock EA et al., 1999). The Sonic hedgehog (Shh) gene is 
expressed in the epithelium of the male urogenital sinus and is not regulated by 
testosterone. Shh has also been shown to be critical for prostate development; however, it 
has not been studied in relation to hypospadias (Podlasek CA et al., 1999). Genetic 
impairment of Shh during development may be involved in hypospadias and is consistent 
with the well-established role of Shh in limb development (Cohn MJ & Bright PE, 1999). 
Genetic mutations could theoretically interfere indirectly with fetal testis and adrenal 
testosterone production and with the adequate virilization of the urogenital sinus and 
external genitalia during embryogenesis if the conversion of testosterone to DHT by 5┙-
reductase is interrupted. In addition, any errors in the activity of enzymes involved in 
converting cholesterol to testosterone could indirectly affect urogenital virilization. 
Aaronson et al. determined the incidence of defects in three major enzymes in the 
biosynthetic pathway leading to the production of testosterone (3┚-hydroxysteroid 
dehydrogenase, 17┙-hydroxylase, and 17,20-lyase) in 30 boys with fully descended testes 
but with penoscrotal or proximal shaft hypospadias. One-half of the boys had evidence of 
impaired function of one or more of these enzymes, suggesting that there was an underlying 
defect in the biosynthesis of testosterone (Aaronson IA et al., 1997). 
6.4 Steroid 5-alpha reductase type 2 (SRD5A2)  
The differentiation of the male external genitalia (penis, scrotum and urethra) depends upon 
conversion of testosterone (T) to dihydrotestosterone (DHT) via the enzyme steroid 5 alpha-
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reductase (SRD5A) located in the urogenital tubercle. DHT also initiates differentiation of 
the urogenital sinus into the prostate while it inhibits the development of the vesico-vaginal 
septum. T and DHT bind to the same intracellular androgen receptor and interact with a 
cognate DNA response element to regulate gene expression. Even though T and DHT are 
active via the same androgen receptor, these hormones produce distinct biological 
responses. The reasons for this are not clear at the molecular level; however, DHT binds to 
the androgen receptor more avidly than T, and the DHT-receptor complex is more 
efficiently transformed to the DNA-binding state than is the T-receptor complex (Siiteri P & 
Wilson J., 1974; Russell DW &Wilson JD., 1994; Zhu Y-S et al., 1998). 
The role of T and DHT in formation of the male genital tract is vividly illustrated in men 
with congenital SRD5A enzyme deficiency, who are known as male pseudohermaphrodites 
(Zhu Y-S et al., 1998; Griffin J, & Wilson J., 1989; Imperato-McGinley J et al., 1987). They 
have a normal XY karyotype but ambiguous external genitalia, and thus are reared as 
females in many cases. T and estrogen (E) levels are normal to elevated, but DHT levels are 
reduced. These individuals lack Mullerian duct derivatives, while T-dependent Wolffian 
duct derivatives (the epididymides, seminal vesicles, vas deferens) are present. The DHT-
dependent external genitalia are abnormal, however, and a small phallus, bifid scrotum, 
blind vaginal pouch, and varying degrees of hypospadias are present. Two different 
isozymes of SRD5A have been identified in humans: one is located in genital tissue and the 
prostate, with an optimum pH of 5.5 (type 2; SRD5A2), and the other is found in nongenital 
skin and the liver, with an optimal pH of 6–9 (type 1; SRD5A1) (Moore R, & Wilson J, 1976). 
Male pseudohermaphrodites have deficiencies only in the SRD5A2 enzyme, the gene for 
which is located on the short arm of chromosome 2 (2p23). The gene for SRD5A1 is located 
on the short arm of chromosome 5 (5p15), and is normal in male pseudohermaphrodites 
(Andersson S et al., 1991; Thigpen A et al., 1992). In children, SRD5A1 expression is localized 
to the sebaceous gland in nongenital skin and is markedly elevated at puberty (Thigpen A et 
al., 1993). The virilization of male pseudohermaphrodites at puberty may be influenced by 
synthesis of DHT in nongenital skin viaSRD5A1 activity. As a means of diagnosing SRD5A2 
deficiency in children, T/DHT ratios have been measured in serum after hCG stimulation. 
Excretion of 5┙/5┚ steroid metabolites, and enzyme activity in cultured fibroblasts from 
genital skin have also been examined (Peterson R et al., 1985). These parameters are highly 
variable and difficult to interpret in prepubertal children, and T/DHT ratios are increased 
only in the most severely affected patients (Hiort O et al., 1996; Sinnecker GH et al., 1996). 
More recently, direct evaluation of allelic variants in the SRD5A2 gene has been used to 
diagnose SRD5A2 deficiency (Hiort O et al., 1996). 
6.5 Androgen receptor gene 
The AR gene plays a critical role in male sexual differentiation by mediating the biological 
effects of gonadal androgens. There are more than 150 mutations described in the AR gene 
that give rise to androgen insensitivity syndrome (MacLean HE et al., 1995). Most reports of 
AR gene mutations in individuals with hypospadias have included patients with additional 
genitourinary malformations, and the disorder analyzed was partial androgen insensitivity 
syndrome rather than nonsyndromic hypospadias. Mutations of the androgen receptor 
coding sequence are infrequent in patients with isolated hypospadias (Allera A et al., 1995; 
Klocker H et al., 1995; Sutherland RW et al., 1996).  
In a study of 63 cases of severe hypospadias obtained from a single centre, cases were 
evaluated for a spectrum of known risk factors, including patient history, physical 
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examination, karyotyping, hormonal evaluation, and assay of genes involved in androgen 
action and metabolism. In 31% of cases, the underlying aetiology was identified. Of these, 
17% were due to complex genetic syndromes, such as Smith-Lemli-Opitz and Opitz-Frias . 
Sex chromosomal anomalies, such as XY mosaicisms, accounted for 9.5% of cases. Isolated 
causes in one case each were the androgen insensitivity syndrome and 5┙-reductase type 2 
deficiency Also, in patients with elevated T to DHT ratios, no mutations were found in the 
SRD5A2 gene. These findings indicate that gene mutations in the SRD5A2, and AR genes 
may not be common in patients drawn from the general population with nonsyndromic 
hypospadias (Boehmer AL et al., 1999). Until larger studies are undertaken, however, the 
role of genetic factors in genes controlling androgen action and metabolism will not be 
clearly understood. Evaluations of genotype, as well as exposure to endocrine disrupting 
chemicals, are likely to be important in explaining the majority of cases of nonsyndromic 
hypospadias. 
7. Risk factors for hypospadias 
Several studies have found that male infants with hypospadias have lower birth weight, 
shorter length of gestation and/or evidence of growth retardation in utero (Sweet RA et al., 
1974; Akre O et al., 1999; Hussain N et al.. 2002).  
The recent study by Hussain et al contains a systematic evaluation of all these risk factors. A 
retrospective cohort study of 6,746 male infants admitted to neonatal intensive care units 
(NICU) at the University of Connecticut from 1987–2000 was conducted. Overall, 1.66% of 
male infants had a diagnosis of nonsyndromic hypospadias, and there was a 10-fold 
increase in the birth prevalence over the 13-year period of the study. Hypospadias was 
significantly more common in infants who had poor intrauterine growth (10th percentile) as 
measured by birth weight, length, and head circumference. The proportionate decrease in 
all of these growth parameters suggests that the primary insult occurred early, during the 
first trimester of pregnancy (Hussain N et al. 2002). There were no differences between 
singletons and multiple-gestation births, but the frequency was significantly higher among 
firstborn infants (1.9%) compared to all other infants (0.9%). There was a higher occurrence 
(35%) of the more severe forms of hypospadias (second- and third-degree) in this study 
compared with other studies, (Avellan L, 1975) indicating that both the incidence and 
severity were increasing over time (Hussain N et al. 2002). Common environmental factors 
that had an impact on intrauterine growth and morphogenesis of the genital tract were 
considered to be the cause. Exposure to EDC (Endocrine Disrupting Chemicals) was 
implicated, as significant levels were found in aquatic life in proximity to the study site in 
Connecticut (Hussain N et al. 2002). While these findings are notable, and diagnostic criteria 
for hypospadias were rigorously controlled, the prevalence of hypospadias among infants in 
an NICU environment cannot be extrapolated to the general population.  An additional risk 
factor for hypospadias is parental subfertility, which has been identified as delayed 
childbearing in several studies (Fisch H et al., 2001; Fritz G, & Czeizel AE, 1996). A 50% 
increase in severe cases has been demonstrated in children of mothers 35 years old 
compared to mothers 20 years old (Fisch H et al., 2001; Michael P.Porter et al., 2005). A 
correlation between paternal subfertility and increased risk of hypospadias has also been 
found (Fisch H et al., 2001). Abnormalities of the scrotum or testes (e.g., cryptorchidism, 
varicocele, hydrocele, and atrophic testes) were found in 34% of index fathers whose sons 
had hypospadias, compared to 3% of control fathers in a study conducted by  Fritz and 
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Czeizel (Sweet RA, 1974; Fritz G, & Czeizel AE, 1996). They also found that 24% of fathers 
with affected sons had signs of subfertility (such as decreases in sperm density, motility, and 
morphology) that required medical treatment, compared to 6% of controls (Fritz G, & 
Czeizel AE, 1996). Subfertile males are now reproducing at a higher rate due to 
improvements in assisted-reproduction techniques, and this may be contributing to the 
increased occurrence of hypospadias (Czeizel A, 1985; Fritz G, & Czeizel AE, 1996).  
Additional evidence that paternal subfertility is a risk factor for hypospadias has come from 
studies of birth outcome following in vitro fertilization (IVF) procedures. A five-fold 
increased risk for hypospadias has been found in infants conceived by IVF procedures in the 
Greater Baltimore Medical Center as compared to state-wide incidence figures in Maryland 
(Silver RI, 1999). These findings have been confirmed in subsequent studies using the 
Swedish Medical Birth Registry (Wennerholm UB et al., 2000; Ericson A & Kallen B, 2001). 
No increased risk for hypospadias was found after standard IVF in Sweden; however, there 
was an approximately three-fold increased risk (95% CI, 1.4 –5.4) after intracytoplasmic 
sperm injection (ICSI), a specific IVF procedure that is undertaken when sperm quality is 
poor (Wennerholm UB et al., 2000; Ericson A & Kallen B, 2001). Women undergoing IVF 
procedures typically receive treatment with progesterone in the first trimester to support the 
pregnancy after embryo transfer postulated that this treatment is the cause of increased risk 
for hypospadias following IVF procedures (Silver RI, 1999). Experimental studies have 
shown that progestins administered to laboratory animals during pregnancy can cause 
hypospadias (Goldman AS et al., 1967; Dean HJ, 1984). The epidemiologic evidence, 
however, does not support an association between increased risk for hypospadias and first 
trimester exposure to progestins found in oral contraceptives, hormones for pregnancy 
support, and/or hormone-based pregnancy tests (Sweet RA et al., 1974; Aarskog D, 1979; 
Czeizel A, 1979; Mau G 1981; Monteleone NR et al., 1981; Calzolari E, 1989; Kallen B et al., 
1991). A meta-analysis of human studies also did not find an association between progestin 
exposures and external genital anomalies in male infants (summary OR, 1.09; 95% CI, 0.90 –
1.32) (Raman-Wilms L et al., 1995). In addition, Wennerholm et al. (Wennerholm UB, 2000) 
and Ericson and Kallen (Ericson A & Kallen B, 2001) found in the Swedish Medical Birth 
Registry that an increased risk for hypospadias was specific for ICSI, and not for all the 
other IVF procedures in which progestin support was administered. These investigators 
concluded that confounding by paternal subfertility explained the association between ICSI 
and increased risk for hypospadias. The transfer of genes involving androgen action and 
metabolism from fathers with poor sperm quality to their sons was considered the most 
likely cause (Fritz G & Czeizel AE, 19960. 
In other reports white race, and pre-existing diabetes were also found to be associated with 
hypospadias in male offspring (Michael P.Porter et al.,2005). Reports concerning use of 
maternal drugs during early pregnancy, strongly associate the use of valproic acid with 
infant hypospadias, amongst other abnormalities (Carla Arpino et al., 2000 ). 
8. Testicular dysgenesis syndrome (TDS) and related male reproductive 
disorders 
Several investigators have reported adverse trends in male reproductive health, including 
increasing incidence of testicular cancer, cryptorchidism ie undescended testis, hypospadias 
and low semen quality (Adami et al., 1994; Forman & Moller, 1994; Carlsen et al. 1992; Swan 
et al., 1997; Andersen et al., 2000; Toppari et al., 1996; Paulozzi et al., 1997). It has been 
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proposed that all these disorders have common orign in fetal life and thus they all represent 
different symptoms of the same underlying entity called testicular dysgenesis syndrome 
(TDS) (Skakkebaek et al., 2001; Sharpe, 2003; Asklund et al., 2004). The observation that the 
occurrence of one disorder increases the risk of the occurrence of another disorder gives 
epidemiological evidence for the existence of TDS (Skakkebaek et al., 2001). Additonally the 
disorders of the male reproductive health share common risk factors.  Small for gestational age 
infants have increased risk of developing undescended testis, hypospadias and testicular 
cancer (Moller and Weidner, 1999; English et al., 2003). The rapid increase of reproductive 
disorders and the geographical clustering of these disorders, point to environmental, life style 
and occupational trends rather than the accumulation of genomic defects, as the most likely 
cause of TDS (Virtanen HE. Et al., 2005). Animal studies have shown that several chemicals 
including pesticides, such as vinclozolin, procymidone, DDE, can cause TDS linked disorders 
(Skakkebaek et al., 2001; Damgaard et al., 2002; Fischer, 2004) 
9. Endocrine disrupting chemicals 
The familial clustering of hypospadias among first degree relatives has traditionally been 
perceived as evidence of a genetic component in the aetiology of this anomaly. However, 
exposure to environmental contaminants is now being considered in familial clusters 
because of the high probability of shared exposures among first degree relatives (Baskin LS 
et al., 2001). 
As mentioned earlier the risk of developing hypospadias amongst relatives can be as high as 
10%. This shows that the cause of hypospadias is mainly genetic for these individuals. The 
hypothesis of shared exposure on endocrine disrupting chemicals cannot alone justify the 
high incidence rate of hypospadias in familial clusters. The same hypothesis on the other 
hand cannot be overlooked since these agents have been shown to interfere with male 
sexual differentiation. 
Several environmental antiandrogens have been identified in rodent models that interfere 
with male sexual differentiation at environmentally relevant doses (William R. Kelce et al., 
1997; Gray LE et al., 1999; Tamura H  et al., 2001; Gray LE et al., 2000 Gray LE et al., 2001). 
At relatively low in utero doses, antiandrogens reduce anogenital distance and induce 
transient nipple development in the neonatal rat. At mid-doses, hypospadias, agenesis of 
the sex accessory tissues, and retained nipples occur, while at the highest doses 
undescended testes and epididymal agenesis are seen. Fetal tissue concentrations of 10–20 
ppm of the DDT metabolite, p,p_-DDE, an AR antagonist, are sufficient to produce these 
antiandrogenic effects in the rat fetus (William R. Kelce et al., 1997). These concentrations 
are similar to those measured in first-trimester human fetal tissues in the late 1960s. The 
pesticides vinclozolin, procymidone, linuron, and fenitrothion are also AR antagonists that 
produce dose-response effects on the developing male reproductive system (Gray LE et al., 
1999; Tamura H et al., 2001).  
Phthalate esters (PE) inhibit testosterone synthesis during fetal life, and produce dose-
related abnormalities of the male reproductive tract similar to those caused by the AR 
antagonists (Gray LE et al., 2000). The PE have effects at extremely low in utero doses, and 
no-effect levels could not be found for the most sensitive endpoint, reduction in anogenital 
distance in male neonates (Gray LE et al., 2000). Prenatal administration of a single low dose 
of dioxin (50 –1,000 ng TCDD/kg) alters differentiation of androgen-dependent tissues; 
however, the mechanism of action involves interaction with the hormone-like receptor, 
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AhR, rather than the AR (Gray LE et al., 2001). Attempts to extrapolate findings from these 
rodent models to humans have been problematic. It can be difficult to determine whether 
effects obtained at doses employed in rodent models are relevant to human environmental 
exposures (Gray LE et al., 2001). An even greater problem is the difficulty of accurately 
measuring in utero human exposure to environmental agents for comparison. A number of 
epidemiology studies have been conducted concerning pesticide exposures of fathers 
employed as gardeners, agricultural pilots, or aerial sprayers (Roan CC et al., 1984;  Rupa DS 
et al., 1991;  Smith AH et al.,1982; Garcia AM, 1988). These studies have provided evidence, 
(some  authors claim this evidence as very weak  if any), that these types of occupational 
exposures result in adverse pregnancy outcomes (Roan CC et al., 1984; Rupa DS et al., 1991; 
Smith AH et al.,1982). A review of epidemiology studies published in 1980–1996 on the 
effects of agricultural occupation (and presumably pesticide exposure) on congenital 
malformations has been conducted. Of 34 published studies, few resulted in significant 
associations between birth defects and pesticide exposure (Garcia AM, 1988). Problems 
inherent in most of the studies were the use of occupational title or residence as a surrogate 
for pesticide exposure, the assessment of outcome through parental interview rather than 
medical records, and small study size. Recommendations from this and other reviews are 
that exposure to specific active ingredients or at least chemical classes must be 
quantitatively evaluated before assessment of effects on reproductive function can be 
accurately determined (Nurimen T, 1995). Regardless of these methodological issues, 
however, enough positive associations have been reported to warrant further investigation 
of pesticide effects on human reproduction. 
10. Conclusion 
There is substantial evidence for increases in the birth prevalence of hypospadias in the 
United States and in Europe. Several clinical risk factors have been identified, including 
intrauterine growth reduction and paternal subfertility, particularly when accompanied by 
assisted-reproduction procedures. Familial clustering has been well documented, and may 
involve both genetic and environmental risk factors.  A number of candidate genes that 
control androgen action and metabolism are logical choices for genomic evaluation in 
population-based studies, including the SRD5A2, HSD17B3, and the AR genes. 
The role of EDC exposure in the aetiology of hypospadias in human populations is far from 
clear (C M. Rochelau, 2009). Major improvements in methodologies to measure 
environmental exposures are needed to determine the role of environmental exposures in 
the increased rates of hypospadias. The need of a prospective study that will accurately 
determine the exposure to EDC and quantitavely measure this exposure in a large sample of 
the population is needed.  
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